These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22485020)

  • 21. Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy.
    Holly R; Morton GC; Sankreacha R; Law N; Cisecki T; Loblaw DA; Chung HT
    Brachytherapy; 2011; 10(4):299-305. PubMed ID: 21190903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate HDR brachytherapy catheter displacement between planning and treatment delivery.
    Whitaker M; Hruby G; Lovett A; Patanjali N
    Radiother Oncol; 2011 Dec; 101(3):490-4. PubMed ID: 21889221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New implant technique for separation of the seminal vesicle and rectal mucosa for high-dose-rate prostate brachytherapy.
    Yoshida K; Kuroda S; Yoshida M; Fujita Y; Sakai M; Nohara T; Kawashima A; Takahashi T; Tohda A; Oka T; Yamazaki H; Kuriyama K
    Brachytherapy; 2007; 6(3):180-6. PubMed ID: 17606414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional image-based high-dose-rate interstitial brachytherapy for mobile tongue cancer.
    Yoshida K; Takenaka T; Akiyama H; Yamazaki H; Yoshida M; Masui K; Kotsuma T; Baek S; Uesugi Y; Shimbo T; Yoshikawa N; Arika T; Koretsune Y; Yoshioka Y; Narumi Y; Tanaka E
    J Radiat Res; 2014 Jan; 55(1):154-61. PubMed ID: 23732769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer.
    Simnor T; Li S; Lowe G; Ostler P; Bryant L; Chapman C; Inchley D; Hoskin PJ
    Radiother Oncol; 2009 Nov; 93(2):253-8. PubMed ID: 19854524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Needle displacement during HDR brachytherapy in the treatment of prostate cancer.
    Damore SJ; Syed AM; Puthawala AA; Sharma A
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1205-11. PubMed ID: 10725633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
    Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.
    Hermesse J; Biver S; Jansen N; Lenaerts E; Nickers P
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):269-76. PubMed ID: 19775833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
    Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study.
    Martin T; Baltas D; Kurek R; Röddiger S; Kontova M; Anagnostopoulos G; Dannenberg T; Buhleier T; Skazikis G; Tunn U; Zamboglou N
    Strahlenther Onkol; 2004 Apr; 180(4):225-32. PubMed ID: 15057433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions.
    Kim Y; Hsu IC; Lessard E; Vujic J; Pouliot J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1208-16. PubMed ID: 15234057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
    J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: a prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study.
    Herrmann MK; Kertesz T; Gsänger T; Bloch E; Pollul G; Bouabdallaoui M; Strauss A; Herrmann M; Christiansen H; Wolff HA; Hess CF; Hille A
    Radiat Oncol; 2012 Feb; 7():24. PubMed ID: 22348595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer.
    Stenmark MH; Vineberg K; Ten Haken RK; Hamstra DA; Feng M
    Med Dosim; 2012; 37(3):240-4. PubMed ID: 22189029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.
    Shin KH; Kim TH; Cho JK; Kim JY; Park SY; Park SY; Kim DY; Chie EK; Pyo HR; Cho KH
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):197-204. PubMed ID: 16169676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractionated perioperative high dose rate brachytherapy using a tissue equivalent bendy applicator.
    Könemann S; Deppe K; Schuck A; Micke O; Schäfer U; Lindner N; Hillmann A; Dietl KH; Kronholz HL; Annweiler H; Willich NA
    Br J Radiol; 2002 May; 75(893):453-9. PubMed ID: 12036840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.